OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cardiovascular Benefits of GLP-1 Receptor Agonists in Patients Living with Obesity or Overweight: A Meta-analysis of Randomized Controlled Trials
Gustavo de Oliveira Almeida, Thiago Nienkötter, Caroline Cristine Almeida Balieiro, et al.
American Journal of Cardiovascular Drugs (2024) Vol. 24, Iss. 4, pp. 509-521
Closed Access | Times Cited: 11

Showing 11 citing articles:

Cardiovascular outcomes with semaglutide by severity of chronic kidney disease in type 2 diabetes: the FLOW trial
Kenneth W. Mahaffey, Katherine R. Tuttle, Mustafa Arici, et al.
European Heart Journal (2024)
Open Access | Times Cited: 8

Breaking Ground: From CPAP Treatment to the First Medicine for OSA Patients with Obesity
Daniil Lisik, Ding Zou
Current Pulmonology Reports (2025) Vol. 14, Iss. 1
Open Access | Times Cited: 1

Effects of liraglutide on body composition in people living with obesity or overweight: A systematic review
P Schmidt, Eric Pasqualotto, Henrique Vilar dos Santos, et al.
Obesity Research & Clinical Practice (2025)
Closed Access | Times Cited: 1

Novel Antidiabetic Drugs and Risk of Venous Thromboembolism: A Literature Review
Qingui Chen, Rayna J.S. Anijs, Judith P.L. Verlaan, et al.
Seminars in Thrombosis and Hemostasis (2025)
Closed Access | Times Cited: 1

Efficacy and Safety of Tirzepatide for Weight Management in Non-Diabetic Obese Individuals: A Narrative Review
Mohammed Sallam, Johan Snygg, Sara El Ghandour, et al.
Obesities (2025) Vol. 5, Iss. 2, pp. 26-26
Open Access

Venous thrombosis and obesity: from clinical needs to therapeutic challenges
Federica La Rosa, Fabrizio Montecucco, Luca Liberale, et al.
Internal and Emergency Medicine (2024)
Open Access | Times Cited: 2

Beyond Weight Loss: Evaluating Cardiovascular Advantages of GLP-1 Receptor Agonists
Teresa Vezza, Víctor M. Víctor
American Journal of Cardiovascular Drugs (2024) Vol. 24, Iss. 4, pp. 505-507
Closed Access | Times Cited: 1

Glucagon-like Peptide 1 Receptor Agonists in Cardio-Oncology: Pathophysiology of Cardiometabolic Outcomes in Cancer Patients
Vincenzo Quagliariello, Maria Laura Canale, Irma Bisceglia, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 20, pp. 11299-11299
Open Access | Times Cited: 1

Navigating the Evolving Roles of GLP-1 Agonists Safely and Effectively
Kyle Ockerman, Heather Furnas, Amy Sheer, et al.
Aesthetic Surgery Journal (2024) Vol. 44, Iss. 11, pp. 1241-1245
Closed Access

Page 1

Scroll to top